Our data demonstrate that induction of MCP-2/CCL8 by mycobacteria depends on activation of TLR2/PI3K/Akt and p38 signaling pathway, and provide guidelines for design of novel diagnostic and therapeutic measures in TB based on the biomarker MCP-2/CCL8. This evidence concerns the gene TLR2 and tuberculosis.